Skip to content

Pfizer PFE Return on assets

Return on assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
8.1%+2.5pp
Eli Lilly logo
Eli LillyLLY
24.5%+10.1pp
Johnson & Johnson logo
Johnson & JohnsonJNJ
10.7%-1.3pp
Merck & Co. logo
Merck & Co.MRK
7.3%-8.4pp
Amgen logo
AmgenAMGN
8.6%+2.1pp
Incyte logo
IncyteINCY
21.9%+21.5pp

Other financials

Income statement

See full
Revenue$14.5B+5.4%
Gross profit$10.9B+0.3%
Net income$2.7B-9.4%
EPS (diluted)$0.47-9.6%

Balance sheet

See full
Cash & equivalents$1.8B+18.8%
Total debt$64.4B+5.0%
Total equity$90.1B-0.3%
Total assets$207.62B-0.2%

Cash flow

See full
Operating cash flow$2.6B+12.0%
CapEx$436.0M-22.7%
Free cash flow$2.2B+23.0%

Valuation

See full
Market cap$147.73B+11.1%
Enterprise value$210.4B+9.2%
P/E12.2×
P/S2.3×+0.2×

Profitability

See full
Gross margin73.5%+1.2pp
Net margin15.7%

Returns & leverage

See full
Return on equity10.6%
Debt / equity0.7×0.0×
Current ratio1.2×0.0×

Where this comes from

Calculated from Pfizer’s reported figures.

Based on trailing twelve months.

The official record: Pfizer’s 10-Q, filed November 4, 2025, on SEC EDGAR. View the filing →

Ask your AI about Pfizer's return on assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pfizer's return on assets?
Pfizer (PFE) reported return on assets of 4.6% in Q3 2025.
What does return on assets mean?
How much profit the company squeezes out of everything it owns.
How do you interpret return on assets?
Higher means more productive assets. Unlike ROE, it is unaffected by leverage, so a wide ROE-minus-ROA gap flags a heavily levered balance sheet.
How does return on assets compare across companies?
Best compared within an industry — asset intensity varies enormously across sectors. Not meaningful for banks, whose assets are largely financial.